AI for Predicting Market Access Barriers in Rare Diseases Predicting market access barriers in rare diseases is a complex process. AI is helping simplify this process by identifying regulatory, pricing, and reimbursement challenges before they emerge. This article explores how AI can support pharma and biotech companies in improving market access planning for rare disease…